pravastatin has been researched along with Insulin Resistance in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (6.45) | 18.2507 |
2000's | 15 (48.39) | 29.6817 |
2010's | 14 (45.16) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Favero, BC; García-Arevalo, M; Gomes-Marcondes, MCC; Lorza-Gil, E; Oliveira, HCF | 1 |
Beck, B; Donner, D; du Toit, EF; Headrick, JP; Oi, M; Peart, J; Wendt, L | 1 |
Hori, E; Imaeda, K; Kikuchi, C; Matsunaga, T; Okayama, N; Suzuki, T | 1 |
Ganesan, S; Ito, MK | 1 |
Choi, H; Han, SH; Koh, KK; Lee, K; Lee, Y; Lim, S; Oh, PC; Quon, MJ; Sakuma, I; Shin, EK | 1 |
Zhao, SP; Zhao, W | 1 |
Kokkola, T; Modi, S; Yaluri, N | 1 |
Han, SH; Kim, SJ; Koh, KK; Lee, Y; Park, JB; Quon, MJ; Shin, EK | 1 |
Huang, CN; Lee, IT; Lee, WJ; Ou, HC; Sheu, WH | 1 |
Baker, WL; Coleman, CI; Talati, R; White, CM | 1 |
Harada, M; Otani, M; Otsuki, M; Yamamoto, M | 1 |
Koh, KK; Quon, MJ; Sakuma, I | 1 |
Arai, H; Minami, M; Murayama, T; Tamura, Y; Yokode, M | 1 |
Atanassova, P; Bełtowski, J; Chaldakov, GN; Jamroz-Wiśniewska, A; Kula, W; Rusek, M | 1 |
Choi, H; Han, SH; Koh, KK; Lee, K; Quon, MJ; Sakuma, I; Shin, EK | 1 |
Andreotti, F; Basile, F; Biaggi, A; Bracaglia, M; Caruso, A; De Waure, C; Di Cesare, C; Di Nicuolo, F; Di Simone, N; Di'Ipolito, S; Donati, L; Ianniello, F; Labianca, A; Paradisi, G; Quagliozzi, L; Viggiano, M | 1 |
Faust, M | 1 |
Güçlü, F; Hekimsoy, Z; Kirmaz, C; Ozmen, B | 1 |
Amm-Azar, M; Azar, RR; Gannagé-Yared, MH; Germanos-Haddad, M; Halaby, G; Khalifé, S; Neemtallah, R | 1 |
Matsui, T; Sato, T; Takeuchi, M; Yamagishi, S | 1 |
Ichihara, K; Kanda, M; Kasai, T; Keimatsu, N; Satoh, K; Sun, F; Takaguri, A | 1 |
Hayashi, J; Kikuchi, K; Maeda, N; Okada, K; Sawayama, Y; Tatsukawa, M | 1 |
Kadonosono, K; Okamura, A; Takano, T; Utsunomiya, H; Yamakawa, T | 1 |
Chen, Y; Kohno, M; Kosaka, H; Mizukawa, M; Ohmori, K; Shinomiya, K; Yoshida, J; Zeng, Y; Zhang, L | 1 |
Dagli, N; Karaca, I; Yavuzkir, M | 1 |
Fujioka, D; Kawabata, K; Kitta, Y; Kobayashi, T; Kodama, Y; Kugiyama, K; Nakamura, T; Obata, JE; Saito, Y; Takano, H; Yano, T | 1 |
Chen, M; Ichiki, T; Imayama, I; Inanaga, K; Miyazaki, R; Ohtsubo, H; Sunagawa, K | 1 |
Chien, YH; Lee, WJ; Lee, WL; Liang, KW; Sheu, WH; Tang, YJ; Tsou, SS | 1 |
Albarrán, OG; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E | 1 |
Horikoshi, H; Ito, T; Shiomi, M; Tsujita, Y; Tsukada, T | 1 |
Dumont, AS; Dumont, RJ; Fedak, PM; Hyndman, ME; Kassell, NF; Sutherland, GR; Verma, S | 1 |
2 review(s) available for pravastatin and Insulin Resistance
Article | Year |
---|---|
Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis.
Topics: Anticholesteremic Agents; Blood Glucose; Blood Pressure; Body Size; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Patient Selection; Pravastatin; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Triglycerides | 2010 |
Differential metabolic effects of distinct statins.
Topics: Adiponectin; Animals; Atorvastatin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Fluorobenzenes; Heptanoic Acids; Homeostasis; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Mice; Pravastatin; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2011 |
8 trial(s) available for pravastatin and Insulin Resistance
Article | Year |
---|---|
Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia.
Topics: Angiotensin II Type 1 Receptor Blockers; Body Mass Index; Brachial Artery; C-Reactive Protein; Coronary Artery Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Lipids; Male; Middle Aged; Phenotype; Pravastatin; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2013 |
Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients.
Topics: Adiponectin; C-Reactive Protein; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin; Insulin Resistance; Leptin; Lipoproteins; Male; Middle Aged; Pravastatin; Simvastatin; Treatment Outcome; Vasodilation | 2009 |
Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients.
Topics: Female; Fluorobenzenes; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Male; Middle Aged; Pravastatin; Pyrimidines; Rosuvastatin Calcium; Single-Blind Method; Sulfonamides | 2013 |
Effect of pravastatin on endothelial function and endothelial progenitor cells in healthy postmenopausal women.
Topics: Anticholesteremic Agents; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Endothelial Cells; Endothelium, Vascular; Female; Humans; Insulin Resistance; Lipoproteins, LDL; Middle Aged; Multivariate Analysis; Postmenopause; Pravastatin; Stem Cells; Triglycerides | 2012 |
Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients.
Topics: Adiponectin; Adult; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Leptin; Male; Middle Aged; Placebos; Pravastatin; Reference Values | 2005 |
Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia.
Topics: Aged; Anticholesteremic Agents; Blood Glucose; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Glycated Hemoglobin; Hemoglobins; Humans; Hypercholesterolemia; Imidazoles; Insulin Resistance; Male; Middle Aged; Pravastatin; Resins, Synthetic | 2007 |
The effects of high dose pravastatin and low dose pravastatin and ezetimibe combination therapy on lipid, glucose metabolism and inflammation.
Topics: Administration, Oral; Adult; Aged; Anticholesteremic Agents; Azetidines; Blood Glucose; C-Reactive Protein; Cholesterol; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation; Insulin; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Pravastatin; Treatment Outcome; Triglycerides | 2007 |
Early Improvements in insulin sensitivity and inflammatory markers are induced by pravastatin in nondiabetic subjects with hypercholesterolemia.
Topics: Anticholesteremic Agents; Cholesterol; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Inflammation; Insulin Resistance; Male; Middle Aged; Pravastatin; Triglycerides | 2008 |
21 other study(ies) available for pravastatin and Insulin Resistance
Article | Year |
---|---|
Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice.
Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Cell Line; Diabetes Mellitus, Experimental; Fasting; Female; Glucose Intolerance; Homeostasis; Hypercholesterolemia; Insulin; Insulin Resistance; Insulin Secretion; Mice, Inbred C57BL; Models, Biological; Muscle Fibers, Skeletal; Muscle Proteins; Myotoxicity; Oxidative Stress; Phosphorylation; Pravastatin; Proteolysis; Receptors, LDL; Signal Transduction; Superoxides | 2019 |
Pravastatin improves risk factors but not ischaemic tolerance in obese rats.
Topics: Animals; Blood Glucose; Body Weight; Diet, Carbohydrate Loading; Diet, High-Fat; Disease Models, Animal; Heart; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Insulin Resistance; Lipid Peroxidation; Male; Mitochondria; Mitochondrial Dynamics; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Obesity; Pravastatin; Rats; Rats, Wistar; Risk Factors | 2018 |
[Effect of Statins on Glycemic Status and Plasma Adiponectin Concentrations in Patients with Type 2 Diabetes Mellitus and Hypercholesterolemia].
Topics: Adiponectin; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Male; Middle Aged; Molecular Weight; Pravastatin | 2019 |
Coenzyme Q10 ameliorates the reduction in GLUT4 transporter expression induced by simvastatin in 3T3-L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Anticholesteremic Agents; Azetidines; Diabetes Mellitus; Drug Interactions; Ezetimibe; Glucose Transporter Type 4; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Mice; Pravastatin; Simvastatin; Ubiquinone | 2013 |
Different effects of statins on induction of diabetes mellitus: an experimental study.
Topics: Atorvastatin; Cell Cycle; Cell Survival; Cells, Cultured; Diabetes Mellitus; Dose-Response Relationship, Drug; Glucose; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Muscle, Skeletal; Pravastatin; Quinolines; Rosuvastatin Calcium; Signal Transduction; Structure-Activity Relationship | 2015 |
Simvastatin induces insulin resistance in L6 skeletal muscle myotubes by suppressing insulin signaling, GLUT4 expression and GSK-3β phosphorylation.
Topics: Animals; Cell Line; Cholesterol; Glucose; Glucose Transporter Type 4; Glycogen; Glycogen Synthase Kinase 3 beta; Insulin; Insulin Resistance; Muscle Fibers, Skeletal; Phosphorylation; Pravastatin; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Simvastatin | 2016 |
Metabolic syndrome abating the beneficial effect of pravastatin treatment on adhesion of endothelium by monocytes in subjects with hypercholesterolemia.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Glucose; C-Reactive Protein; Cell Adhesion; Endothelium, Vascular; Female; Humans; Hypercholesterolemia; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Middle Aged; Monocytes; Patient Selection; Pravastatin; Triglycerides; Young Adult | 2009 |
Effect of long- and short-term treatments with pravastatin on diabetes mellitus and pancreatic fibrosis in the Otsuka-Long-Evans-Tokushima fatty rat.
Topics: Adipose Tissue, White; Animals; Apoptosis; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Fibrosis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Organ Size; Pancreas; Peroxidase; Pravastatin; Rats; Rats, Long-Evans; Superoxide Dismutase; Time Factors; Transforming Growth Factor beta1; Triglycerides; Tumor Necrosis Factor-alpha | 2010 |
Differential effect of statins on diabetic nephropathy in db/db mice.
Topics: Adiposity; Albuminuria; Animals; Blood Pressure; Body Weight; Creatinine; Diabetic Nephropathies; Fluorobenzenes; Insulin Resistance; Male; Mice; Oxidative Stress; Pravastatin; Pyrimidines; Quinolines; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides | 2011 |
Opposite effects of pravastatin and atorvastatin on insulin sensitivity in the rat: role of vitamin D metabolites.
Topics: Adipokines; Adipose Tissue; Animals; Atorvastatin; Biomarkers; Blood Glucose; Calcifediol; Calcitriol; Cholecalciferol; Fasting; Fatty Acids, Nonesterified; Glucose Clamp Technique; Glycerol; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Insulin; Insulin Resistance; Liver; Male; Muscle, Skeletal; Pravastatin; Pyrroles; Rats; Rats, Wistar; Time Factors | 2011 |
[Statin treatment in type 2 diabetes. Is it a must today?].
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus, Type 2; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Insulin Resistance; Life Style; Middle Aged; Placebos; Pravastatin; Primary Prevention; Risk Factors; Simvastatin | 2003 |
Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome.
Topics: Diabetes Mellitus, Type 2; Female; Humans; Insulin Resistance; Metabolic Syndrome; Middle Aged; Pravastatin | 2004 |
Protective role of pravastatin in the pathogenesis of the metabolic syndrome.
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Female; Humans; Insulin Resistance; Male; Metabolic Syndrome; Models, Biological; Models, Theoretical; Obesity; Pravastatin | 2006 |
HMG-CoA reductase inhibitors do not improve glucose intolerance in spontaneously diabetic Goto-Kakizaki rats.
Topics: Animals; Atorvastatin; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Glucose Intolerance; Glucose Tolerance Test; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Pravastatin; Pyrroles; Rats; Rats, Wistar; Simvastatin | 2005 |
Pravastatin improves insulin resistance in dyslipidemic patients.
Topics: Aged; Anticholesteremic Agents; Carotid Arteries; Dyslipidemias; Female; Glucose; Humans; Insulin Resistance; Male; Middle Aged; Pravastatin; Ultrasonography | 2005 |
Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes.
Topics: Adiponectin; Adipose Tissue; Animals; Anticholesteremic Agents; Atorvastatin; Chemokine CCL2; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression Regulation; Glucose; Heptanoic Acids; Hypertriglyceridemia; Insulin Resistance; Leptin; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Pravastatin; Pyrroles; Rats; Rats, Long-Evans; Rats, Mutant Strains; RNA, Messenger; Transforming Growth Factor beta1; Ventricular Dysfunction, Left | 2007 |
Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-alpha-treated cardiomyocytes in association with improved glucose uptake.
Topics: Acetylcysteine; Adiponectin; Administration, Oral; Animals; Animals, Newborn; Antioxidants; Blood Glucose; Cells, Cultured; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Acids; Glucose; Hydrogen Peroxide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Ligation; Lipids; Male; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Pravastatin; Rats; Rats, Sprague-Dawley; Receptors, Adiponectin; Recombinant Proteins; RNA Interference; RNA, Messenger; RNA, Small Interfering; Time Factors; Tumor Necrosis Factor-alpha | 2007 |
Inhibition of balloon injury-induced neointimal formation by olmesartan and pravastatin in rats with insulin resistance.
Topics: Angioplasty, Balloon; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Carotid Artery Diseases; Carotid Artery Injuries; Carotid Artery, Common; Cell Count; Cell Proliferation; Fructose; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Immunohistochemistry; Insulin Resistance; Male; Pravastatin; Rats; Rats, Sprague-Dawley; Stem Cells; Tetrazoles | 2007 |
Effects of chronic combined treatment with captopril and pravastatin on the progression of insulin resistance and cardiovascular alterations in an experimental model of obesity in dogs.
Topics: Animals; Anticholesteremic Agents; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cardiovascular Diseases; Cholesterol; Coronary Vessels; Disease Models, Animal; Disease Progression; Dogs; Drug Therapy, Combination; Heart; Insulin; Insulin Resistance; Linear Models; Male; Multivariate Analysis; Myocardium; Obesity; Pravastatin; Triglycerides | 1998 |
Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Blood Glucose; Cholesterol, LDL; Chromans; Coronary Vessels; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Glucose Tolerance Test; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperinsulinism; Hyperlipoproteinemia Type II; Hypoglycemic Agents; Insulin Resistance; Male; Pravastatin; Rabbits; Thiazoles; Thiazolidinediones; Troglitazone; Xanthomatosis | 1999 |
Improvement of endothelial function in insulin-resistant carotid arteries treated with pravastatin.
Topics: Animals; Carotid Stenosis; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Hypertension; Insulin Resistance; Male; Nitric Oxide; Pravastatin; Rats; Rats, Sprague-Dawley; Risk Factors; Stroke; Vascular Resistance | 2001 |